Effects of Telemonitoring and Telemedicine Service for Hypertensive Care

NACompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

August 31, 2013

Conditions
Hypertension
Interventions
PROCEDURE

Telemonitoring

"The subjects who are assigned in the Telemonitoring group will be provided Blood Pressure monitor, body composition analyzer, and remote monitoring device.~The subjects who are assigned in the Telemonitoring group should visit the site once per every 2 months (8 weeks), and they should measure their blood pressure using a provided blood pressure monitor twice a day during study period (once after first morning urination and once before going to bed). After measurement of blood pressure and body composition, the subjects should make the transmission terminals of remote monitoring device situate near transmission terminal of Smart Care PC and transmit measured information through Smart Care PC into a centralized server of Smart Care Center."

PROCEDURE

Telemonitoring & Telemedicine

"The subjects who are assigned in the Telemonitoring \& Telemedicine group should perform the same remote monitoring procedures as the subjects in the Telemonitoring group.~Since the remote visit substitute for a face to face visit, subjects should reserve the time for remote visit in each clinical trial center. A primary doctor or remote medical doctor should provide medical consultation to the subjects through videotelephony using the remote monitoring device and then issue electronic prescriptions."

OTHER

control group

"\- The subjects who are assigned in the control group will be provided blood Pressure Monitor (Self BP measuring).~The subjects who are assigned in the control group should perform the same blood pressure measurement (2 times a day) same as the test group during the study, and measured results should be recorded in a diary of self blood pressure measurement. In addition, the subjects should visit the site once per every two months (8 weeks)."

Trial Locations (3)

Unknown

Keimyung University Dongsan Medical Center, Daegu

Yeungnam University Medical Center, Daegu

Yonsei University Health System, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

LG Electronics Inc.

INDUSTRY

collaborator

Purdue University

OTHER

lead

Chang Hee, Lee

INDUSTRY

NCT01335984 - Effects of Telemonitoring and Telemedicine Service for Hypertensive Care | Biotech Hunter | Biotech Hunter